Skip to content

Sarcopenia (loss of muscle mass and function) and physical performance as predictors of clinical outcome in patients on dialysis

A prospective longitudinal study investigating the effect of sarcopenia and physical performance on 9, 12 and 18 month morbidity and mortality in dialysis patients aged over 60 years.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12612000048886
Enrollment
75
Registered
2012-01-10
Start date
2011-12-21
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

A research study into how muscle bulk, strength and physical performance predict clinical outcomes in patients on dialysis. If the hypothesis proves to be correct, then these simple tests could be used when people are on dialysis or considering commencing dialysis. The results could highlight patients at increased risk of suffering medical complications during dialysis treatments.

Interventions

Measurement of: - biochemical parameters by serum assay of albumin, haematocrit, urea, cholesterol, CRP, transferrin, TNF-alpha - muscle mass using a Fresenius bioimpedance spectrometer - muscle strength using Jamar hand dynamometer for grip strength and isometric muscle strength dynamometer for leg extension - functional muscle capacity using repeated chair stands, timed up-and-go, and 6 minute walk test - subjective nutritional status assessment using the validated "Subjective Global Analysis"

Measurement of: - biochemical parameters by serum assay of albumin, haematocrit, urea, cholesterol, CRP, transferrin, TNF-alpha - muscle mass using a Fresenius bioimpedance spectrometer - muscle strength using Jamar hand dynamometer for grip strength and isometric muscle strength dynamometer for leg extension - functional muscle capacity using repeated chair stands, timed up-and-go, and 6 minute walk test - subjective nutritional status assessment using the validated "Subjective Global Analysis" questionnaire. Testing is performed during a single 45 minute assessment session at baseline, biochemical results are accessed from medical records, and TNF-alpha will be assayed from serum samples.

Sponsors

Associate Professor Grahame Elder
Lead SponsorIndividual

Eligibility

Sex/Gender
All
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Dialysis patients

Exclusion criteria

Cardiac pacemaker or implanted defibrillator Limb amputation

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 11, 2026